Streptomyces griseus AdpA is the central transcription factor in the A-factor regulatory cascade and activates a number of genes that are required for both secondary metabolism and morphological differentiation, leading to the onset of streptomycin biosynthesis as well as aerial mycelium formation and sporulation. The DNA-binding domain of AdpA consists of two helix-turn-helix DNAbinding motifs and shows low nucleotide-sequence specificity. To reveal the molecular basis of the low nucleotide-sequence specificity, an attempt was made to obtain cocrystals of the DNA-binding domain of AdpA and several kinds of duplex DNA. The best diffracting crystal was obtained using a 14-mer duplex DNA with two-nucleotide overhangs at the 5 0 -ends. The crystal diffracted X-rays to 2.8 Å resolution and belonged to space group C222 1 , with unit-cell parameters a = 76.86, b = 100.96, c = 101.25 Å . The Matthews coefficient (V M = 3.71 Å 3 Da À1 ) indicated that the crystal was most likely to contain one DNA-binding domain of AdpA and one duplex DNA in the asymmetric unit, with a solvent content of 66.8%.
Introduction
The filamentous bacterial genus Streptomyces is characterized by morphological differentiation culminating in sporulation and by its ability to produce various antibiotics as secondary metabolites. In Streptomyces griseus, morphological differentiation and secondary metabolism are triggered by a chemical signalling molecule called A-factor (2-isocapryloyl-3R-hydroxymethyl--butyrolactone) at an extremely low concentration (Horinouchi & Beppu, 2007; Horinouchi, 2007) . AdpA is the central transcription factor in the A-factor regulatory cascade and activates a number of genes that are required for both secondary metabolism and morphological differentiation, leading to the onset of streptomycin biosynthesis as well as aerial mycelium formation and sporulation (Ohnishi et al., 2005) . AdpA consists of two domains, a ThiJ/PfpI/DJ-1-like dimerization domain in the N-terminal portion and a DNA-binding domain in the C-terminal portion, and belongs to the AraC/XylS family of transcriptional regulators (Yamazaki et al., 2004) . The C-terminal DNA-binding domain (DBD) of AdpA is characterized by two helix-turn-helix (HTH) DNA-binding motifs (Gallegos et al., 1997; Tobes & Ramos, 2002) . A consensus AdpA-binding sequence, 5 0 -TGGCSNGWWY-3 0 (where S is G or C, W is A or T, Y is T or C and N is any nucleotide), was revealed by a uracil-interference assay and missing T and GA interference assays on several AdpA-binding sites followed by gel mobility-shift assays on systematically mutated binding sites (Yamazaki et al., 2004) . The DNA-binding specificity of AdpA is much lower than those of other well known regulators from bacteria. AdpA directly controls >500 genes; to the best of our knowledge, the AdpA regulon appears to be the largest regulon in bacteria (Higo et al., 2012) . The low DNA-binding specificity of AdpA enables binding to many sites on the chromosome, which facilitates the regulation of many genes. Thus, the low nucleotide-sequence specificity of the DBD of AdpA (hereafter referred to as AdpA-DBD) is a very important feature of this global transcriptional regulator. In order to reveal the molecular mechanism of the low nucleotide-sequence specificity of AdpA-DBD, we cocrystallized AdpA-DBD with its target duplex DNAs. Here, we report a cocrystal of AdpA-DBD and a 14-mer duplex DNA that diffracted X-rays to 2.8 Å resolution.
Materials and methods

Overexpression and purification
The gene encoding the DBD (residues 215-340) of S. griseus AdpA (NCBI gene ID 6209784) was amplified by PCR from the genomic DNA of S. griseus and cloned into the NdeI/BamHI site of pET-28a (Novagen) to obtain the expression plasmid for AdpA-DBD with an N-terminal 6ÂHis tag. The deduced amino-acid sequence of the recombinant protein was MGSSHHHHHHSSGLVPRGSHM-GQERYLDRSLPEEIGSDPLAEVVAWALEHLHEQFDVETLA-ARAYMSRRTFDRRFRSLTGSAPLQWLITQRVLQAQRLLETS-DYSVDEVAGRCGFRSPVALRGHFRRQLGSSPAAYRAAYRA-RRPQG, where the amino-acid sequence of AdpA-DBD is shown in bold. The recombinant protein was overexpressed in Escherichia coli Rosetta (DE3) cells harbouring the above-mentioned expression plasmid at 298 K overnight without addition of IPTG. The cultured cells were harvested by centrifugation at 3000g and 277 K for 20 min. The cells were resuspended in 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 10%(v/v) glycerol on ice and disrupted by sonication. After centrifugation at 40 000g for 60 min, the supernatant was applied onto an Ni-NTA agarose column (Qiagen). The bound protein was washed and eluted with buffer solutions consisting of 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10%(v/v) glycerol supplemented with 20 and 250 mM imidazole, respectively. The eluted protein was dialyzed against 20 mM MES pH 6.0, 300 mM NaCl, 10%(v/v) glycerol, applied onto a Resource S 6 ml column (GE Healthcare) pre-equilibrated with 20 mM MES pH 6.0, 300 mM NaCl, 10%(v/v) glycerol and eluted with a linear gradient of 300-1000 mM NaCl. The eluted protein was then applied onto a Superdex 75 10/30 HR column (GE Healthcare) and eluted with 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10%(v/v) glycerol. The purified protein was dialyzed against 10 mM MES pH 6.0, 100 mM NaCl, 10%(v/v) glycerol. All column chromatography was performed at 277 K.
Preparation of the protein-DNA complex and crystallization
The oligonucleotides were purchased from Operon, Tokyo. An equimolar mixture of two complementary oligonucleotides was subjected to annealing by lowering the temperature from 368 to 277 K to obtain duplex DNAs. The AdpA-DBD-duplex DNA complexes were prepared by adding the AdpA-DBD solution to the duplex DNA solution in a 1.0:1.2 molar ratio and incubating the mixture at 277 K for 10 min. The complex solutions were then concentrated to a protein concentration of 8 mg ml À1 (corresponding to 500 mM) using a Vivaspin 15R concentrator (molecular-weight cutoff 10 000; Sartorius). Crystallization experiments were performed at 277 K (and 283 K for optimization) using the sitting-drop vapourdiffusion method. Initial crystallization screening was performed using the commercial crystallization screening kits Crystal Screen HT, Index HT and SaltRx HT (Hampton Research) and Wizard I, II and III (Emerald BioSystems); each drop was prepared manually by mixing 0.7 ml protein-DNA complex solution with 0.7 ml reservoir solution and was equilibrated against 30 ml reservoir solution. The precipitant concentration and pH of the reservoir solution were then optimized using a two-dimensional grid screen, in which each crystallization drop was prepared by mixing 2.0 ml protein-DNA complex solution with 2.0 ml reservoir solution and was equilibrated against 200 ml reservoir solution to obtain larger crystals. Initial diffraction tests were performed using a home-source X-ray generator (Rigaku FR-E) equipped with a Rigaku R-AXIS VII detector at 100 K, using a final concentration of 20%(v/v) ethylene glycol as a cryoprotectant.
X-ray diffraction data collection and processing
Each AdpA-DBD-duplex DNA complex crystal was soaked in reservoir solution supplemented with a final concentration of 20%(v/v) ethylene glycol for several seconds for cryoprotection. Each crystal was then mounted on a cryoloop and flash-cooled to 95 K in a nitrogen stream for X-ray diffraction data collection. An X-ray diffraction data set consisting of 150 images was collected on beamline AR-NE3A at the Photon Factory, Tsukuba, Japan using X-rays with a wavelength of 1.0000 Å , an ADSC Quantum 270 CCD detector, a crystal-to-detector of 300.1 mm, a rotation angle of 1 and an exposure time of 5 s per image. Indexing, integration, scaling and merging of the diffraction data were performed with XDS (Kabsch, 2010) . 
Results and discussion
Recombinant AdpA-DBD was expressed in E. coli and was purified in three steps: immobilized Ni 2+ -affinity, cation-exchange and gelfiltration column chromatography. The molecular weight of purified AdpA-DBD was estimated to be 16.9 kDa by gel-filtration chromatography, indicating that AdpA-DBD exists as a monomer in solution (Fig. 1a) . SDS-PAGE analysis revealed that the purity of AdpA-DBD was greater than 95% (Fig. 1b) . Each pair of complementary oligonucleotides was mixed and subjected to annealing to prepare the duplex DNA (Table 1) . The duplex DNAs used for crystallization (Table 1) contained the consensus AdpA-binding sequence (10 bp) in the centre. Firstly, the optimal DNA length for crystallization was investigated using three kinds of duplex DNAs with blunt ends (DNAs 14, 16 and 18 in Table 1 ). Then, to facilitate end-to-end stacking of DNA molecules, three kinds of duplex DNAs with one-or two-nucleotide 5 0 -overhanging sticky ends (DNAs 15-1, 14-2 and 16-2 in Table 1 ) were used. The protein and DNA were mixed in a 1.0:1.2 molar ratio, concentrated to an AdpA-DBD concentration of 8.0 mg ml À1 (500 mM) and a DNA concentration of 6.0 mg ml À1 (in the case of duplex DNA 14-2; 600 mM) and used for crystallization. Crystals of AdpA-DBD were obtained with the duplex DNAs DNA 16, DNA 18, DNA 14-2 and DNA 15-1. The quality of each crystal was judged by its ability to diffract X-rays in two diffraction images ( Table 1) . Crystals of the AdpA-DBD-duplex DNA 14-2 complex, which were first obtained using condition D5 of Crystal Screen HT [0.1 M sodium HEPES pH 7.5, 10%(v/v) 2-propanol, 20%(w/v) PEG 4000] at 277 K in the initial screening, diffracted X-rays much better than the other crystals. By optimizing the conditions using a twodimensional grid screen, the best crystal of the AdpA-DBD-duplex DNA 14-2 complex was obtained with a reservoir solution composed of 0.1 M sodium HEPES pH 7.1, 10%(v/v) 2-propanol and 16%(w/v) PEG 4000 at 277 K (Fig. 2, Table 1 ). The largest crystal in Fig. 2 (0.36 Â 0.07 Â 0.05 mm) diffracted X-rays to 2.8 Å resolution (Fig. 3 , Table 1 ). The space group of the crystal was determined to be C222 1 , with unit-cell parameters a = 76.86, b = 100.96, c = 101.25 Å . Datacollection statistics are summarized in Table 2 . The Matthews coefficient (V M = 3.71 Å 3 Da À1 ; Matthews, 1968) Table 1 The duplex DNAs used for cocrystallization with AdpA-DBD.
The consensus AdpA-binding sequence (10 bp) is underlined. 
DNA
Figure 2
Crystals of the AdpA-DBD-duplex DNA 14-2 complex.
Figure 3
A diffraction image of the AdpA-DBD-duplex DNA 14-2 complex. The circle corresponds to a resolution of 2.8 Å . crystal is most likely to contain one AdpA-DBD molecule and one duplex DNA fragment in the asymmetric unit, with a solvent content of 66.8%. Structure determination of the AdpA-DBD-duplex DNA complex is currently under way using the molecular-replacement method with the atomic coordinates of Rob (25% sequence identity; PDB entry 1d5y; Kwon et al., 2000) as a search model.
